Abstract
Objective: Fifty percent of endometrial cancer (EC) cases are attributable to obesity, but most women are unaware of the relationship between their weight and EC risk. There is a dearth of data on the prevalence of endometrial hyperplasia (EH) and EC symptoms in obese women undergoing treatment for overweight/obesity. Our aim was to determine the prevalence of potential EH/EC symptoms among women presenting to a multidisciplinary weight management clinic.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
